NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma

Immunomodulators are effective in controlling hematologic malignancy by initiating or reactivating host antitumor immunity to otherwise poorly immunogenic and immune suppressive cancers. We aimed to boost antitumor immunity in B-cell lymphoma by developing a tumor cell vaccine incorporating α-galact...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mattarollo, Stephen R., West, Alison C., Steegh, Kim, Duret, Helene, Paget, Christophe, Martin, Ben, Matthews, Geoffrey M., Shortt, Jake, Chesi, Marta, Bergsagel, P. Leif, Bots, Michael, Zuber, Johannes, Lowe, Scott W., Johnstone, Ricky W., Smyth, Mark J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2012
Assuntos:
Immunobiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3557399/
https://ncbi.nlm.nih.gov/pubmed/22932803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-04-426643
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados